SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 15-12G - Securities registration termination [Section 12(g)]:
SEC Accession No. 0001104659-24-005276
Filing Date
2024-01-19
Accepted
2024-01-19 17:15:20
Documents
1
Effectiveness Date
2024-01-19

Document Format Files

Seq Description Document Type Size
1 15-12G tm243468d1_1512g.htm 15-12G 9298
  Complete submission text file 0001104659-24-005276.txt   10438
Mailing Address 420 LEXINGTON AVENUE, SUITE 300 NEW YORK NY 10170
Business Address 420 LEXINGTON AVENUE, SUITE 300 NEW YORK NY 10170 (212) 479-2513
Scopus BioPharma Inc. (Filer) CIK: 0001772028 (see all company filings)

IRS No.: 821248020 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 15-12G | Act: 34 | File No.: 001-39788 | Film No.: 24546435
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)